Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.
2.

The cumulative false-positive rate in colorectal cancer screening: a Markov analysis.

Haug U, Coupé VMH.

Eur J Gastroenterol Hepatol. 2020 Jan 21. doi: 10.1097/MEG.0000000000001669. [Epub ahead of print]

PMID:
31990711
3.

Cost-effectiveness of stereotactic body radiation therapy versus video assisted thoracic surgery in medically operable stage I non-small cell lung cancer: A modeling study.

Wolff HB, Alberts L, van der Linden N, Bongers ML, Verstegen NE, Lagerwaard FJ, Hofman FN, Uyl-de Groot CA, Senan S, El Sharouni SY, Kastelijn EA, Schramel FMNH, Coupé VMH.

Lung Cancer. 2020 Mar;141:89-96. doi: 10.1016/j.lungcan.2020.01.011. Epub 2020 Jan 16.

4.

Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.

Alberts L, Wolff HB, Kastelijn EA, Schramel FMNH, Coupe VMH.

Clin Lung Cancer. 2019 Dec 28. pii: S1525-7304(19)30373-0. doi: 10.1016/j.cllc.2019.12.005. [Epub ahead of print] No abstract available.

PMID:
31974061
5.

Prevalence of adjustment disorder among cancer patients, and the reach, effectiveness, cost-utility and budget impact of tailored psychological treatment: study protocol of a randomized controlled trial.

van Beek FE, Wijnhoven LMA, Jansen F, Custers JAE, Aukema EJ, Coupé VMH, Cuijpers P, van der Lee ML, Lissenberg-Witte BI, Wijnen B, Prins JB, Verdonck-de Leeuw IM.

BMC Psychol. 2019 Dec 23;7(1):89. doi: 10.1186/s40359-019-0368-y.

6.

Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.

Komor MA, Bosch LJ, Coupé VM, Rausch C, Pham TV, Piersma SR, Mongera S, Mulder CJ, Dekker E, Kuipers EJ, van de Wiel MA, Carvalho B, Fijneman RJ, Jimenez CR, Meijer GA, de Wit M.

J Pathol. 2020 Mar;250(3):288-298. doi: 10.1002/path.5369. Epub 2020 Jan 13.

7.

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.

Bosch LJW, Melotte V, Mongera S, Daenen KLJ, Coupé VMH, van Turenhout ST, Stoop EM, de Wijkerslooth TR, Mulder CJJ, Rausch C, Kuipers EJ, Dekker E, Domanico MJ, Lidgard GP, Berger BM, van Engeland M, Carvalho B, Meijer GA.

Am J Gastroenterol. 2019 Dec;114(12):1909-1918. doi: 10.14309/ajg.0000000000000445.

8.

Efficacy and cost-utility of the eHealth application 'Oncokompas', supporting patients with incurable cancer in finding optimal palliative care, tailored to their quality of life and personal preferences: a study protocol of a randomized controlled trial.

Schuit AS, Holtmaat K, Hooghiemstra N, Jansen F, Lissenberg-Witte BI, Coupé VMH, van Linde ME, Becker-Commissaris A, Reijneveld JC, Zijlstra JM, Sommeijer DW, Eerenstein SEJ, Verdonck-de Leeuw IM.

BMC Palliat Care. 2019 Oct 23;18(1):85. doi: 10.1186/s12904-019-0468-8.

9.

The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.

Kang YJ, Killen J, Caruana M, Simms K, Taylor N, Frayling IM, Snowsill T, Huxley N, Coupe VM, Hughes S, Freeman V, Boussioutas A, Trainer AH, Ward RL, Mitchell G, Macrae FA, Canfell K.

Med J Aust. 2020 Feb;212(2):72-81. doi: 10.5694/mja2.50356. Epub 2019 Oct 8.

10.

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data.

Jongeneel G, Klausch T, van Erning FN, Vink GR, Koopman M, Punt CJA, Greuter MJE, Coupé VMH.

Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32629. [Epub ahead of print]

PMID:
31424568
11.

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study.

den Uil SH, van den Broek E, Coupé VMH, Vellinga TT, Delis-van Diemen PM, Bril H, Belt EJT, Kranenburg O, Stockmann HBAC, Belien JAM, Meijer GA, Fijneman RJA.

BMC Gastroenterol. 2019 Aug 16;19(1):146. doi: 10.1186/s12876-019-1063-4.

12.

Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.

Alberts L, Wolff HB, Kastelijn EA, Lagerwaard FJ, Hofman FN, Sharouni SYE, Schramel FMNH, Coupe VMH.

Clin Lung Cancer. 2019 Sep;20(5):370-377.e3. doi: 10.1016/j.cllc.2019.04.001. Epub 2019 Apr 25.

PMID:
31182416
13.

Stage-specific disease recurrence and survival in localized and regionally advanced cutaneous melanoma.

Leeneman B, Franken MG, Coupé VMH, Hendriks MP, Kruit W, Plaisier PW, van Ruth S, Verstijnen JAMC, Wouters MWJM, Blommestein HM, Uyl-de Groot CA.

Eur J Surg Oncol. 2019 May;45(5):825-831. doi: 10.1016/j.ejso.2019.01.225. Epub 2019 Feb 5.

PMID:
30765270
14.

Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer.

Révész D, Engelhardt EG, Tamminga JJ, Schramel FMNH, Onwuteaka-Philipsen BD, van de Garde EMW, Steyerberg EW, de Vet HCW, Coupé VMH.

J Cancer Educ. 2020 Apr;35(2):345-351. doi: 10.1007/s13187-019-1471-8.

15.

Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.

Engelhardt EG, Révész D, Tamminga HJ, Punt CJA, Koopman M, Onwuteaka-Philipsen BD, Steyerberg EW, de Vet HCW, Coupé VMH.

BMC Med Inform Decis Mak. 2018 Dec 14;18(1):132. doi: 10.1186/s12911-018-0712-9.

16.

Can patient-reported profiles avoid unnecessary referral to a spine surgeon? An observational study to further develop the Nijmegen Decision Tool for Chronic Low Back Pain.

van Hooff ML, van Dongen JM, Coupé VM, Spruit M, Ostelo RWJG, de Kleuver M.

PLoS One. 2018 Sep 19;13(9):e0203518. doi: 10.1371/journal.pone.0203518. eCollection 2018.

17.

Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia.

Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Greuter MJE, Coupé VMH, Canfell K.

Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1450-1461. doi: 10.1158/1055-9965.EPI-18-0128. Epub 2018 Sep 6.

18.

Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.

Puijk RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, Scheffer HJ, Nielsen K, de Jong MC, de Vries JJJ, Zonderhuis BM, Eker HH, Kazemier G, Verheul H, van der Meijs BB, van Dam L, Sorgedrager N, Coupé VMH, van den Tol PMP, Meijerink MR; COLLISION Trial Group.

BMC Cancer. 2018 Aug 15;18(1):821. doi: 10.1186/s12885-018-4716-8.

19.

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer.

van den Broek E, den Uil SH, Coupé VMH, Delis-van Diemen PM, Bolijn AS, Bril H, Stockmann HBAC, van Grieken NCT, Meijer GA, Fijneman RJA.

Oncotarget. 2018 Jun 29;9(50):29445-29452. doi: 10.18632/oncotarget.25655. eCollection 2018 Jun 29.

20.

Author's Reply.

Reuling EMBP, Dickhoff C, Plaisier PW, Coupé VMH, Mazairac AHA, Lely RJ, Bonjer HJ, Daniels JMA.

Respiration. 2018;96(2):205. doi: 10.1159/000489985. Epub 2018 Jun 28. No abstract available.

21.

Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC.

Sluiter NR, Rovers KP, Salhi Y, Vlek SL, Coupé VMH, Verheul HMW, Kazemier G, de Hingh IHJT, Tuynman JB.

Ann Surg Oncol. 2018 Aug;25(8):2347-2356. doi: 10.1245/s10434-018-6539-x. Epub 2018 May 31.

22.

Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening.

Bronzwaer MES, Greuter MJE, Bleijenberg AGC, IJspeert JEG, Dekker E, Coupé VMH.

BMC Cancer. 2018 Apr 25;18(1):465. doi: 10.1186/s12885-018-4375-9.

23.

Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) Adenomas.

Carvalho B, Diosdado B, Terhaar Sive Droste JS, Bolijn AS, Komor MA, de Wit M, Bosch LJW, van Burink M, Dekker E, Kuipers EJ, Coupé VMH, van Grieken NCT, Fijneman RJA, Meijer GA.

Cancer Prev Res (Phila). 2018 Jul;11(7):403-412. doi: 10.1158/1940-6207.CAPR-17-0317. Epub 2018 Apr 23.

24.

Cost-utility analysis of meaning-centered group psychotherapy for cancer survivors.

van der Spek N, Jansen F, Holtmaat K, Vos J, Breitbart W, van Uden-Kraan CF, Tollenaar RAEM, Cuijpers P, Coupé VMH, Verdonck-de Leeuw IM.

Psychooncology. 2018 Jul;27(7):1772-1779. doi: 10.1002/pon.4726. Epub 2018 Apr 27.

25.

Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.

Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Sarfati D, Greuter MJE, Coupé VMH, Canfell K.

Int J Cancer. 2018 Jul 15;143(2):269-282. doi: 10.1002/ijc.31314. Epub 2018 Mar 8.

26.

Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review.

Kolovos S, Bosmans JE, Riper H, Chevreul K, Coupé VMH, van Tulder MW.

Pharmacoecon Open. 2017 Sep;1(3):149-165. doi: 10.1007/s41669-017-0014-7. Review.

27.

Endobronchial Treatment for Bronchial Carcinoid: Patient Selection and Predictors of Outcome.

Reuling EMBP, Dickhoff C, Plaisier PW, Coupé VMH, Mazairac AHA, Lely RJ, Bonjer HJ, Daniels JMA.

Respiration. 2018;95(4):220-227. doi: 10.1159/000484984. Epub 2018 Feb 12.

28.

Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis.

van den Boorn HG, Engelhardt EG, van Kleef J, Sprangers MAG, van Oijen MGH, Abu-Hanna A, Zwinderman AH, Coupé VMH, van Laarhoven HWM.

PLoS One. 2018 Feb 8;13(2):e0192310. doi: 10.1371/journal.pone.0192310. eCollection 2018. Review.

29.

Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non-Small Cell Lung Cancer.

Wolff HB, Alberts L, Kastelijn EA, Lissenberg-Witte BI, Twisk JW, Lagerwaard FJ, Senan S, El Sharouni SY, Schramel FMNH, Coupé VMH.

J Thorac Oncol. 2018 May;13(5):689-698. doi: 10.1016/j.jtho.2018.01.021. Epub 2018 Jan 31.

30.

Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.

Lew JB, St John DJB, Xu XM, Greuter MJE, Caruana M, Cenin DR, He E, Saville M, Grogan P, Coupé VMH, Canfell K.

Lancet Public Health. 2017 Jul;2(7):e331-e340. doi: 10.1016/S2468-2667(17)30105-6. Epub 2017 Jun 26.

31.

Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program.

Vleugels JLA, Greuter MJE, Hazewinkel Y, Coupé VMH, Dekker E.

Endosc Int Open. 2017 Dec;5(12):E1197-E1207. doi: 10.1055/s-0043-113565. Epub 2017 Nov 22.

32.

Cost-effectiveness of different strategies for diagnosis of uncomplicated urinary tract infections in women presenting in primary care.

Bosmans JE, Coupé VMH, Knottnerus BJ, Geerlings SE, Moll van Charante EP, Ter Riet G.

PLoS One. 2017 Nov 29;12(11):e0188818. doi: 10.1371/journal.pone.0188818. eCollection 2017.

33.

Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.

Bosch LJW, de Wit M, Pham TV, Coupé VMH, Hiemstra AC, Piersma SR, Oudgenoeg G, Scheffer GL, Mongera S, Sive Droste JT, Oort FA, van Turenhout ST, Larbi IB, Louwagie J, van Criekinge W, van der Hulst RWM, Mulder CJJ, Carvalho B, Fijneman RJA, Jimenez CR, Meijer GA.

Ann Intern Med. 2017 Dec 19;167(12):855-866. doi: 10.7326/M17-1068. Epub 2017 Nov 21.

PMID:
29159365
34.

MODEL-BASED COST-EFFECTIVENESS OF CONVENTIONAL AND INNOVATIVE CHEMO-RADIATION IN LUNG CANCER.

Bongers ML, de Ruysscher D, Oberije C, Lambin P, Uyl-de Groot CA, Belderbos J, Coupé VMH.

Int J Technol Assess Health Care. 2017 Jan;33(6):681-690. doi: 10.1017/S0266462317000939. Epub 2017 Nov 10.

PMID:
29122046
35.

Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial.

Ter Wee MM, Coupé VM, den Uyl D, Blomjous BS, Kooijmans E, Kerstens PJ, Nurmohamed MT, van Schaardenburg D, Voskuyl AE, Boers M, Lems WF.

RMD Open. 2017 Oct 25;3(2):e000502. doi: 10.1136/rmdopen-2017-000502. eCollection 2017.

36.

Decision support tools in low back pain.

Coupé VMH, van Hooff ML, de Kleuver M, Steyerberg EW, Ostelo RWJG.

Best Pract Res Clin Rheumatol. 2016 Dec;30(6):1084-1097. doi: 10.1016/j.berh.2017.07.002. Epub 2017 Aug 5. Review.

PMID:
29103551
37.

Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?

Jansen F, Coupé VMH, Eerenstein SEJ, Leemans CR, Verdonck-de Leeuw IM.

Support Care Cancer. 2018 Apr;26(4):1221-1231. doi: 10.1007/s00520-017-3945-8. Epub 2017 Nov 3.

38.

Size and shape of the associations of glucose, HbA1c, insulin and HOMA-IR with incident type 2 diabetes: the Hoorn Study.

Ruijgrok C, Dekker JM, Beulens JW, Brouwer IA, Coupé VMH, Heymans MW, Sijtsma FPC, Mela DJ, Zock PL, Olthof MR, Alssema M.

Diabetologia. 2018 Jan;61(1):93-100. doi: 10.1007/s00125-017-4452-7. Epub 2017 Oct 10.

39.

Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.

Greuter MJE, de Klerk CM, Meijer GA, Dekker E, Coupé VMH.

Ann Intern Med. 2017 Oct 17;167(8):544-554. doi: 10.7326/M16-2891. Epub 2017 Oct 3.

PMID:
28973514
40.

Decision support systems for incurable non-small cell lung cancer: a systematic review.

Révész D, Engelhardt EG, Tamminga JJ, Schramel FMNH, Onwuteaka-Philipsen BD, van de Garde EMW, Steyerberg EW, Jansma EP, De Vet HCW, Coupé VMH.

BMC Med Inform Decis Mak. 2017 Oct 2;17(1):144. doi: 10.1186/s12911-017-0542-1.

41.

Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer.

Bosch LJW, Trooskens G, Snaebjornsson P, Coupé VMH, Mongera S, Haan JC, Richman SD, Koopman M, Tol J, de Meyer T, Louwagie J, Dehaspe L, van Grieken NCT, Ylstra B, Verheul HMW, van Engeland M, Nagtegaal ID, Herman JG, Quirke P, Seymour MT, Punt CJA, van Criekinge W, Carvalho B, Meijer GA.

Oncotarget. 2017 Jun 27;8(38):63140-63154. doi: 10.18632/oncotarget.18702. eCollection 2017 Sep 8.

42.

Effectiveness, cost-utility and implementation of a decision aid for patients with localised prostate cancer and their partners: study protocol of a stepped-wedge cluster randomised controlled trial.

Al-Itejawi HHM, van Uden-Kraan CF, van de Ven PM, Coupé VMH, Vis AN, Nieuwenhuijzen JA, van Moorselaar JA, Verdonck-de Leeuw IM.

BMJ Open. 2017 Sep 15;7(9):e015154. doi: 10.1136/bmjopen-2016-015154.

43.

Clinical Usefulness of Tools to Support Decision-making for Palliative Treatment of Metastatic Colorectal Cancer: A Systematic Review.

Engelhardt EG, Révész D, Tamminga HJ, Punt CJA, Koopman M, Onwuteaka-Philipsen BD, Steyerberg EW, Jansma IP, De Vet HCW, Coupé VMH.

Clin Colorectal Cancer. 2018 Mar;17(1):e1-e12. doi: 10.1016/j.clcc.2017.06.007. Epub 2017 Jun 24.

44.

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.

Coebergh van den Braak RRJ, van Rijssen LB, van Kleef JJ, Vink GR, Berbee M, van Berge Henegouwen MI, Bloemendal HJ, Bruno MJ, Burgmans MC, Busch ORC, Coene PPLO, Coupé VMH, Dekker JWT, van Eijck CHJ, Elferink MAG, Erdkamp FLG, van Grevenstein WMU, de Groot JWB, van Grieken NCT, de Hingh IHJT, Hulshof MCCM, Ijzermans JNM, Kwakkenbos L, Lemmens VEPP, Los M, Meijer GA, Molenaar IQ, Nieuwenhuijzen GAP, de Noo ME, van de Poll-Franse LV, Punt CJA, Rietbroek RC, Roeloffzen WWH, Rozema T, Ruurda JP, van Sandick JW, Schiphorst AHW, Schipper H, Siersema PD, Slingerland M, Sommeijer DW, Spaander MCW, Sprangers MAG, Stockmann HBAC, Strijker M, van Tienhoven G, Timmermans LM, Tjin-A-Ton MLR, van der Velden AMT, Verhaar MJ, Verkooijen HM, Vles WJ, de Vos-Geelen JMPGM, Wilmink JW, Zimmerman DDE, van Oijen MGH, Koopman M, Besselink MGH, van Laarhoven HWM; Dutch Pancreatic Cancer Group, Dutch Upper GI Cancer Group and PLCRC working group.

Acta Oncol. 2018 Feb;57(2):195-202. doi: 10.1080/0284186X.2017.1346381. Epub 2017 Jul 19.

PMID:
28723307
45.

Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial.

van der Hout A, van Uden-Kraan CF, Witte BI, Coupé VMH, Jansen F, Leemans CR, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM.

Trials. 2017 May 22;18(1):228. doi: 10.1186/s13063-017-1952-1.

46.

Splenic volume differentiates complicated and non-complicated celiac disease.

van Gils T, Nijeboer P, van Waesberghe JHT, Coupé VM, Janssen K, Zegers JA, Nurmohamed SA, Kraal G, Jiskoot SC, Bouma G, Mulder CJ.

United European Gastroenterol J. 2017 Apr;5(3):374-379. doi: 10.1177/2050640616663571. Epub 2016 Aug 17.

47.

Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F-FDG-PET-CT and/or diffusion-weighted MRI.

Greuter MJ, Schouten CS, Castelijns JA, de Graaf P, Comans EF, Hoekstra OS, de Bree R, Coupé VM.

BMC Cancer. 2017 Apr 11;17(1):256. doi: 10.1186/s12885-017-3254-0.

48.

Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study.

van Lanschot MC, Carvalho B, Coupé VM, van Engeland M, Dekker E, Meijer GA.

BMC Cancer. 2017 Feb 7;17(1):116. doi: 10.1186/s12885-017-3078-y.

49.

A Review on Cost-Effectiveness and Cost-Utility of Psychosocial Care in Cancer Patients.

Jansen F, van Zwieten V, Coupé VM, Leemans CR, Verdonck-de Leeuw IM.

Asia Pac J Oncol Nurs. 2016 Apr-Jun;3(2):125-136. Review.

50.

Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.

Jansen F, Krebber AM, Coupé VM, Cuijpers P, de Bree R, Becker-Commissaris A, Smit EF, van Straten A, Eeckhout GM, Beekman AT, Leemans CR, Verdonck-de Leeuw IM.

J Clin Oncol. 2017 Jan 20;35(3):314-324. doi: 10.1200/JCO.2016.68.8739. Epub 2016 Dec 5.

PMID:
27918712

Supplemental Content

Loading ...
Support Center